Bladder Cancer:
Altor Bioscience (Immunity Bio) Protocol: QUILT-3.032
- a study for patients with BCG unresponsive high-grade non-muscle invasive bladder cancer
https://clinicaltrials.gov/ct2/show/NCT04142359
Altor Bioscience (Immunity Bio) Protocol: QUILT-2.005
- a study for patients with high-grade non-muscle invasive bladder cancer who have never received BCG treatment
https://clinicaltrials.gov/ct2/show/NCT02138734
Prostate Cancer:
Bayer HealthCare Pharmaceuticals, Inc. Protocol: 20609
- a study to compare the effects of treatment between two medications on physical function and daily activity in men with castration-resistant prostate cancer
https://clinicaltrials.gov/ct2/show/NCT04157088
Protocol: V3011102
- a study of a drug for metastatic castration-resistant prostate cancer who have failed a prior therapy
https://clinicaltrials.gov/ct2/show/NCT04844749
Enteric Hyperoxaluria (Kidney Stones):
Novome Biotechnologies, Inc Protocol: NOV-001-CL01
- a study to evaluate a medication in patients with kidney stones
https://clinicaltrials.gov/ct2/show/NCTNCT04909723
Overactive Bladder:
Urovant Sciences Protocol: Composur URO-901-4001
- a study to evaluate an approved drug for overactive bladder on patient satisfaction and quality of life
https://clinicaltrials.gov/ct2/show/NCT05067478
Urovant Sciences Protocol: URO-901-3005
- a study for males age 45 and older with overactive bladder symptoms currently on medication therapy for enlarged prostate
https://clinicaltrials.gov/ct2/show/study/NCT03902080
BPH-Benign Prostatic Hyperplasia (Enlarged Prostate):
Zenflow, Inc Protocol: Breeze
- a device study for treating enlarged prostate in men aged 45 and older
https://clinicaltrials.gov/ct2/show/NCT04131907
Butterfly Medical Ltd Protocol: CL-BM14-001
- a device study for treating enlarged prostate in men 50-80
https://clinicaltrials.gov/ct2/show/NCT05341661
ProVerum,Inc Protocol: The ProVIDE Study
- a device study for treating enlarged prostate in men age 45 and older